194
Participants
Start Date
July 29, 2015
Primary Completion Date
February 20, 2019
Study Completion Date
March 23, 2020
paclitaxel
paclitaxel 80 mg/m2 i.v. (Days 1, 8, and 15)
Reparixin
reparixin oral tablets 1200 mg t.i.d. continuing from D 1 to Day 21 of 28-day cycle
placebo
placebo oral tablets 1200 mg t.i.d. continuing from D 1 to Day 21 of 28-day cycle
Cliniques Universitaires Saint- LUC UCL, Brussels
Universitair Ziekenhuis Antwerpen, Edegem
Algemeen Ziekenhuis Klina, Brasschaat
AZ St Elisabeth, Namur
CHU Ambroise Paré, Mons
Fakultní nemocnice Královské Vinohrady, Prague
Onkologická klinika VFN a 1.LF UK, Prague
Institut Paoli Calmettes, Marseille
Centre François Baclesse, Caen
Bialostockie Centrum Onkologii im. Marii Sklodowskiej - Curie, Bialystok
Fakultní nemocnice v Motole, Onkologická klinika 2. LF UK a FN Motol, Prague
Complejo Hospitalario Universitario La Coruña, A Coruña
Centro Oncológico Regional de Galicia, Servicio de Oncologia Medica, A Coruña
Hematology and Oncology Associates of Northeast PA, Dunmore
Thomas Jefferson University, Philadelphia
Fox Chase Cancer Center, Philadelphia
Centrum Onkologii Ziemi Lubelskiej im. sw. Jana z Dukli, Lublin
Istituto Europeo di Oncologia, Milan
Azienda Ospedaliera, Ospedale San Carlo Borromeo, Milan
Nemocnice Horovice a.s., Hořovice
Fondazione IRCCS Policlinico S. Matteo, Pavia
Waverly Hematology Oncology, Cary
Hospital General Universitario Gregorio Marañon, Madrid
Centro Integral Oncológico Clara Campal, Hospital de Madrid Norte-San Chinarro, Madrid
Atlanta Cancer Care, Alpharetta
Atlanta Cancer Care, Decatur
Northside Hospital, Inc.-Georgia Cancer Specialists, Decatur
Atlanta Cancer Care, Cumming
Northside Hospital, Inc.-Georgia Cancer Specialists, Marietta
Atlanta Cancer Care, Conyers
Northside Hospital, Inc.-Georgia Cancer Specialists, Canton
Ospedale SS Giovanni e Paolo, Venezia
Ospedale dell'Angelo, Mestre
Atlanta Cancer Care, Jonesboro
Southeastern Regional Medical Center, Newnan
Atlanta Cancer Care, Atlanta
Northside Hospital, Inc., Atlanta
Northside Hospital, Inc.-Georgia Cancer Specialists, Sandy Springs
Northside Hospital, Inc.-Georgia Cancer Specialists, Athens
Northside Hospital, Inc.-Georgia Cancer Specialists, Macon
Florida Cancer Specialists, Daytona Beach
Azienda Opspedaliero Universitaria Santa Maria della Misericordia, Udine
Florida Cancer Specialists, West Palm Beach
Mrukmed. Lekarz Beata Madej Mruk i Partner. Spólka Partnerska Oddzial nr 1 w Rzeszowie, Rzeszów
C. Hospital Xeral-Cies, Vigo
Southern Cancer Center, Mobile
Tennessee Oncology PLLC, Chattanooga
Medicale Centre René Gauducheau, Saint-Herblain
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola
University of Michigan Cancer Center, Ann Arbor
Centre Paul Papin, Angers
Fakultni nemocnice Hradec Králové, Hradec Králové
Fox Valley Hematology and Oncology, SC, Appleton
Nuovo Ospedale, Prato
Swedish Covenant, Chicago
Azienda Ospedaliera Ospedali Riuniti Marche Nord, Pesaro
Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Poznan
Mid Illinois Hematology & Oncology Associates, Ltd., Normal
Masaryk Memorial Cancer Institute, Brno
"Ospedale Di Summa-Perrino", Brindisi
Hôpital Européen Georges Pompidou, Paris
Krajská nemocnice T.Bati, a. s., Zlín
MD Anderson Cancer Center, Houston
The Methodist Hospital, Houston
Wojewódzkie Centrum Onkologii, Gdansk
Centre hospitalier de Saint-Brieuc, Yves Le Foll, La Roche-sur-Yon
Centre Hospitalier Universitaire (CHU) De Limoges - Hopital Dupuytren, Limoges
CBCC Global Research a Comprehensive Blood and Cancer Center, Bakersfield
Azienda Ospedaliero - Universitaria, Policlinico Vittorio Emanuele, Catania
Overlake Medical Center, Bellevue
Summit Medical Group, Morristown
Regional Cancer Care Associates, Sparta
Centre Antoine Lacassagne, Nice
Azienda Ospedaliero-Universitaria, Cagliari
Magodent Sp. z o. o., Warsaw
Hospital del Mar, Barcelona
Hospital Universitario Vall d'Hebron, Barcelona
Collaborators (1)
PRA Health Sciences
INDUSTRY
Dompé Farmaceutici S.p.A
INDUSTRY